Stephen Richey, M.D., MPH, FACP

Stephen L. Richey, M.D., MPH, FACP, is board certified in hematology, internal medicine, and medical oncology. Dr. Richey has expertise in the treatment of melanoma, genitourinary (kidney, bladder, prostate, testicular cancers), breast, lung, head and neck, and gastrointestinal cancers. He also has expertise is lymphoma and leukemia. Dr. Richey is a member of the US Oncology Network phase 1 drug development program. He has held positions on the US Oncology Genitourinary Cancer Research Committee, the US Oncology Research Executive Committee, and the Texas Oncology Board of Directors. He is active in clinical research and is the principal investigator of clinical trials or various malignancies. He has expertise in immunotherapy, targeted therapy, and chemotherapy approaches to cancer treatment. Dr. Richey is actively involved in the most current phase I through phase III clinical trials through US Oncology Research Network.